Morgan Stanley
APVO icon

Morgan Stanley’s Aptevo Therapeutics APVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
0
-4
-100% -$4 8101
2025
Q1
$4 Sell
-3,923
Closed -$16.9K ﹤0.01% 8037
2024
Q4
$16.9K Buy
+3,733
New +$16.9K ﹤0.01% 6622
2024
Q3
$35 Hold
194
-$60 ﹤0.01% 7688
2024
Q2
$60 Hold
194
-$910 ﹤0.01% 7449
2024
Q1
$910 Sell
-22,546
Closed -$4.12K ﹤0.01% 7180
2023
Q4
$4.12K Buy
+11,727
New +$4.12K ﹤0.01% 7036
2023
Q3
$3.63K Hold
11,013
-$16.1K ﹤0.01% 6987
2023
Q2
$16.1K Hold
11,013
-$22.4K ﹤0.01% 6636
2023
Q1
$22.4K Sell
11,013
-300
-3% -$26.2K ﹤0.01% 6581
2022
Q4
$26.2K Sell
-7,501
Closed -$57K ﹤0.01% 6560
2022
Q3
$57K Sell
18,814
-3,458
-16% ﹤0.01% 6347
2022
Q2
$80K Sell
22,272
-28,824
-56% -$80K ﹤0.01% 6387
2022
Q1
$300K Sell
51,096
-61,059
-54% -$150K ﹤0.01% 5696
2021
Q4
$883K Buy
+101,127
New +$883K ﹤0.01% 5162
2021
Q3
$170K Buy
11,028
+2,664
+32% -$187K ﹤0.01% 6085
2021
Q2
$187K Buy
8,364
+5,189
+163% -$97K ﹤0.01% 6052
2021
Q1
$97K Sell
3,175
-76
-2% -$119K ﹤0.01% 6026
2020
Q4
$119K Buy
3,251
+2,840
+691% -$3K ﹤0.01% 5837
2020
Q3
$3K Sell
411
-8,147
-95% -$71K ﹤0.01% 6503
2020
Q2
$71K Buy
8,558
+8,177
+2,146% -$1K ﹤0.01% 5542
2020
Q1
$1K Sell
381
-8,761
-96% -$6K ﹤0.01% 6446
2019
Q4
$6K Buy
9,142
+5,136
+128% -$2K ﹤0.01% 6364
2019
Q3
$2K Buy
4,006
+3,856
+2,571% ﹤0.01% 6466
2019
Q2
$0 Hold
150
﹤0.01% 6632
2019
Q1
$0 Sell
150
-458
-75% -$1K ﹤0.01% 6584
2018
Q4
$1K Sell
608
-3,460
-85% -$21K ﹤0.01% 6477
2018
Q3
$21K Sell
4,068
-28,497
-88% -$162K ﹤0.01% 6117
2018
Q2
$162K Sell
32,565
-14,474
-31% -$154K ﹤0.01% 5609
2018
Q1
$154K Buy
47,039
+19,736
+72% -$116K ﹤0.01% 5572
2017
Q4
$116K Sell
27,303
-42,259
-61% -$159K ﹤0.01% 5595
2017
Q3
$159K Sell
69,562
-50,228
-42% -$248K ﹤0.01% 5443
2017
Q2
$248K Buy
119,790
+1,136
+1% -$244K ﹤0.01% 5219
2017
Q1
$244K Sell
118,654
-68,621
-37% -$456K ﹤0.01% 5220
2016
Q4
$456K Sell
-72,817
Closed -$665K ﹤0.01% 4984
2016
Q3
$665K Buy
+260,092
New +$665K ﹤0.01% 4338